Double Helix appoints Sarah Frere-Cook and Ginevra Drinka

pharmafile | June 20, 2011 | Appointment | Medical Communications, Sales and Marketing |  appointment, medical communications, sales and marketing 

Double Helix has boosted its London-based strategic market research team with two new appointments.

Sarah Frere-Cook joins as a research executive and Ginevra Drinka has been appointed as a trainee research executive. 

Sarah was formerly with Hall and Partners heath for a year and a half, during which she developed her knowledge and skills in both qualitative and quantitative healthcare market research.

Advertisement

She has experience across a range of therapy areas including diabetes, clinical nutrition, rheumatoid arthritis, MS, Cushing’s disease and smoking cessation.

Ginevra has four years experience in psychological academic research, having worked on studies covering functional vision loss, ADHD, psychophysiology and adolescent peer group dynamics.

Related Content

Men’s health – a new report from the Department of Health and Social Care

The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

The Gateway to Local Adoption Series

Latest content